Cargando…

Autocrine Signaling of NRP1 Ligand Galectin-1 Elicits Resistance to BRAF-Targeted Therapy in Melanoma Cells

Melanoma cells addicted to mutated BRAF oncogene activity can be targeted by specific kinase inhibitors until they develop resistance to therapy. We observed that the expression of Galectin-1 (Gal-1), a soluble ligand of Neuropilin-1 (NRP1), is upregulated in melanoma tumor samples and melanoma cell...

Descripción completa

Detalles Bibliográficos
Autores principales:	Rizzolio, Sabrina, Corso, Simona, Giordano, Silvia, Tamagnone, Luca
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2020
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7463444/ https://www.ncbi.nlm.nih.gov/pubmed/32784465 http://dx.doi.org/10.3390/cancers12082218

Ejemplares similares

The importance of being CAFs (in cancer resistance to targeted therapies)
por: Rizzolio, Sabrina, et al.
Publicado: (2022)

Expression of NRP-1 and NRP-2 in Endometrial Cancer
por: Oplawski, Marcin, et al.
Publicado: (2019)

NRP1 and synapse formation
por: Ango, Fabrice
Publicado: (2016)

Segregation Analysis of Rare NRP1 and NRP2 Variants in Families with Lymphedema
por: Michelini, Sandro, et al.
Publicado: (2020)

Semaphorin 4D regulates gonadotropin hormone–releasing hormone-1 neuronal migration through PlexinB1–Met complex
por: Giacobini, Paolo, et al.
Publicado: (2008)

VEGF(189) binds NRP1 and is sufficient for VEGF/NRP1-dependent neuronal patterning in the developing brain
por: Tillo, Miguel, et al.
Publicado: (2015)

Analysis of PLXNA1, NRP1, and NRP2 variants in a cohort of patients with isolated hypogonadotropic hypogonadism
por: Men, Meichao, et al.
Publicado: (2021)

BRAF inhibition curtails IFN‐gamma‐inducible PD‐L1 expression and upregulates the immunoregulatory protein galectin‐1 in melanoma cells
por: Górniak, Patryk, et al.
Publicado: (2020)

Galectin-1 as an oncotarget in gliomas and melanomas
por: Lefranc, Florence, et al.
Publicado: (2011)

Transcriptional analysis of metastatic uveal melanoma survival nominates NRP1 as a therapeutic target
por: Bao, Riyue, et al.
Publicado: (2020)

BRaf(V600E) cooperates with Pten silencing to elicit metastatic melanoma
por: Dankort, David, et al.
Publicado: (2009)

Intracellular galectin-7 expression in cancer cells results from an autocrine transcriptional mechanism and endocytosis of extracellular galectin-7
por: Bibens-Laulan, Nathalie, et al.
Publicado: (2017)

NRP1 and MMP9 are dual targets of RNA‐binding protein QKI5 to alter VEGF‐R/ NRP1 signalling in trophoblasts in preeclampsia
por: Yang, Xingyu, et al.
Publicado: (2021)

Autocrine regulation of stomatal differentiation potential by EPF1 and ERECTA-LIKE1 ligand-receptor signaling
por: Qi, Xingyun, et al.
Publicado: (2017)

NRP1 and NRP2 cooperate to regulate gangliogenesis, axon guidance and target innervation in the sympathetic nervous system
por: Maden, Charlotte H., et al.
Publicado: (2012)

Neuropilin 1 (NRP1) hypomorphism combined with defective VEGF-A binding reveals novel roles for NRP1 in developmental and pathological angiogenesis
por: Fantin, Alessandro, et al.
Publicado: (2014)

A CRAF/glutathione-S-transferase P1 complex sustains autocrine growth of cancers with KRAS and BRAF mutations
por: Niitsu, Yoshiro, et al.
Publicado: (2020)

Use of Labelled tLyP-1 as a Novel Ligand Targeting the NRP Receptor to Image Glioma
por: Wu, Hu-bing, et al.
Publicado: (2015)

Role of NRP1 in Bladder Cancer Pathogenesis and Progression
por: Dong, Yang, et al.
Publicado: (2021)

Structural Characterization of Arabidopsis thaliana NAP1-Related Protein 2 (AtNRP2) and Comparison with Its Homolog AtNRP1
por: Kumar, Ashish, et al.
Publicado: (2019)

MicroRNA-9 suppresses the growth, migration, and invasion of malignant melanoma cells via targeting NRP1
por: Xu, Dan, et al.
Publicado: (2016)

Anti-CTLA-4 based therapy elicits humoral immunity to galectin-3 in patients with metastatic melanoma
por: Wu, Xinqi, et al.
Publicado: (2018)

Concomitant BCORL1 and BRAF Mutations in Vemurafenib-Resistant Melanoma Cells()
por: Mologni, Luca, et al.
Publicado: (2018)

NRP1 function and targeting in neurovascular development and eye disease
por: Raimondi, Claudio, et al.
Publicado: (2016)

Role of Nrp1 in controlling cortical inter-hemispheric circuits
por: Martín-Fernández, Fernando, et al.
Publicado: (2022)

Pseudokinase NRP1 facilitates endocytosis of transferrin in the African trypanosome
por: Kumar, Gaurav, et al.
Publicado: (2022)

VEGF binding to NRP1 is essential for VEGF stimulation of endothelial cell migration, complex formation between NRP1 and VEGFR2, and signaling via FAK Tyr407 phosphorylation
por: Herzog, Birger, et al.
Publicado: (2011)

BET and BRAF inhibitors act synergistically against BRAF‐mutant melanoma
por: Paoluzzi, Luca, et al.
Publicado: (2016)

Real-Time Ligand Binding of Fluorescent VEGF-A Isoforms that Discriminate between VEGFR2 and NRP1 in Living Cells
por: Peach, Chloe J., et al.
Publicado: (2018)

Autocrine-based selection of ligands for personalized CAR-T therapy of lymphoma
por: Stepanov, Alexey V., et al.
Publicado: (2018)

IGF1R/IR Mediates Resistance to BRAF and MEK Inhibitors in BRAF-Mutant Melanoma
por: Patel, Hima, et al.
Publicado: (2021)

NRP2 transcriptionally regulates its downstream effector WDFY1
por: Dutta, Samikshan, et al.
Publicado: (2016)

Evaluation of diagnostic efficacy of NRP‐1/CD304 in hematological diseases
por: Liu, Yi‐jun, et al.
Publicado: (2023)

The Oncogenic Signaling Pathways in BRAF-Mutant Melanoma Cells Are Modulated by Naphthalene Diimide-Like G-Quadruplex Ligands
por: Recagni, Marta, et al.
Publicado: (2019)

The Role of Neuropilin-1 (NRP-1) in SARS-CoV-2 Infection: Review
por: Gudowska-Sawczuk, Monika, et al.
Publicado: (2021)

VEGF (Vascular Endothelial Growth Factor) Induces NRP1 (Neuropilin-1) Cleavage via ADAMs (a Disintegrin and Metalloproteinase) 9 and 10 to Generate Novel Carboxy-Terminal NRP1 Fragments That Regulate Angiogenic Signaling
por: Mehta, Vedanta, et al.
Publicado: (2018)

Overcoming resistance to BRAF inhibition in BRAF-mutated metastatic melanoma
por: Spagnolo, Francesco, et al.
Publicado: (2014)

Targeting BRAF for patients with melanoma
por: Arkenau, H-T, et al.
Publicado: (2011)

IL-6 signaling by STAT3 participates in the change from hyperplasia to neoplasia in NRP-152 and NRP-154 rat prostatic epithelial cells
por: Barton, Beverly E, et al.
Publicado: (2001)

Galectin-3 Is a Natural Binding Ligand of MCAM (CD146, MUC18) in Melanoma Cells and Their Interaction Promotes Melanoma Progression
por: Pang, Yaoyu, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_dkvj5leqevlp6inai2mvg6phn4